Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus-Friedrich Bodmann

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Respiratory infectionsSebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studiesXavier Guirao, Miguel Sánchez García, Matteo Bassetti, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studiesWolfgang R Heizmann, Hervé Dupont, Philippe Montravers, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studiesMatteo Bassetti, Christian Eckmann, Klaus Friedrich Bodmann, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studiesPhilippe Montravers, Matteo Bassetti, Hervé Dupont, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studiesChristian Eckmann, Philippe Montravers, Matteo Bassetti, et al.
Infectious Diseases and Therapy|June 12, 2026
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS StudyDominik Jarczak, Stefan Kluge, Martin Kieninger, et al.
Infectious Diseases and Therapy|March 19, 2025
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS StudyKlaus-Friedrich Bodmann, Stefan Hagel, Alessandra Oliva, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 16, 2024
[Clinical acute and emergency medicine curriculum-focus on internal medicine : Recommendations for advanced training in internal medicine in the emergency department], , , et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 16, 2025
[Core curriculum of intensive care and emergency medicine in internal medicine], , , et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Respiratory infectionsSebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studiesXavier Guirao, Miguel Sánchez García, Matteo Bassetti, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studiesWolfgang R Heizmann, Hervé Dupont, Philippe Montravers, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Prescription behaviours for tigecycline in real-life clinical practice from five European observational studiesMatteo Bassetti, Christian Eckmann, Klaus Friedrich Bodmann, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studiesPhilippe Montravers, Matteo Bassetti, Hervé Dupont, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2013
Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studiesChristian Eckmann, Philippe Montravers, Matteo Bassetti, et al.
Infectious Diseases and Therapy|June 12, 2026
Real-World Data on the Use of Intravenous Fosfomycin for the Treatment of Central Nervous System Infections: a Subgroup Analysis from the FORTRESS StudyDominik Jarczak, Stefan Kluge, Martin Kieninger, et al.
Infectious Diseases and Therapy|March 19, 2025
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS StudyKlaus-Friedrich Bodmann, Stefan Hagel, Alessandra Oliva, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|April 16, 2024
[Clinical acute and emergency medicine curriculum-focus on internal medicine : Recommendations for advanced training in internal medicine in the emergency department], , , et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|December 16, 2025
[Core curriculum of intensive care and emergency medicine in internal medicine], , , et al.
Pageof 2